Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
naujokat c, laufer s (2013) targeting cancer stem cells with defined compounds and drugs. j can res upd 2: 36-67. |
|
garza-treviño en, said-fernández sl, martínez-rodríguez hg (2015) understanding the colon cancer stem cells and perspectives on treatment. can cell int 15: 2. |
|
dragu dl, necula lg, bleotu c, diaconu cc, chivu-economescu m (2015) therapies targeting cancer stem cells: current trends and future challenges. world j stem cell 7: 1185. |
|
douglas jn, gardner la, salapa he, levin mc (2016). antibodies to the rna binding protein heterogeneous nuclear ribonucleoprotein a1 colocalize to stress granules resulting in altered rna and protein levels in a model of neurodegeneration in multiple sclerosis. jcci 7:(402). |
|
meyers l, groover cj, douglas j, lee s, brand d, et al. (2014) a role for apolipoprotein ai in the pathogenesis of multiple sclerosis. journal of neuroimmunology 277:176-85. |
|
Naujokat c (2014) monoclonal antibodies against human cancer stem cells. immunotherapy 6: 290-308. |
|
blagodatski a, poteryaev d, katanaev vl (2014) targeting the wnt pathways for therapies. mol cell ther 2: 28. |
|
demarshall c, sarkar a, nagele ep, goldwaser e, godsey g, et al. (2015) chapter one-utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases. international review of neurobiology 122:1-51. |
|
galkin oh, kazmirchuk vye, metalnikova np (2015) heat shock proteins: role in shaping the immune response. research bulletin of the national technical university of ukraine "kyiv polytechnic institute" 3: 12-20. |
|
galkin oy, kazmirchuk be, metalnikov np (2014) heat shock proteins: role in the immune response. research bulletin of ntuu 3. |
|
levin mc, douglas jn, meyers l, lee s, shin y, et al. (2014) neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms. degenerative neurolog neuromusc dis 4:49-63. |
|
singh a (2016) indispensable role of protein in cancer. jpbb 1: 51. |
|
galkin ay, kazmirchuk v, metalnikova np (2014) heat shock proteins: role in formation of immune response. naukovi visti ntuu-kpi 95. |
|
grigoriadis n, pesch v (2015). a basic overview of multiple sclerosis immunopathology. european journal of neurology 22:3-13. |
|
santos tm (2014) processamento intracelular da fibrilina-1 mutada na síndrome de marfan: escape do controle de qualidade pela dissulfeto isomerase proteica. digital library thesis and dessertations. |
|
wang cl (2014) role of p53 and aurora a on g2 / m arrest and apoptosis induced by bortezomib in colorectal. airity library 1: 1-52. |
|
nanavati c, mager de (2017) sequential exposure of bortezomib and vorinostat is synergistic in multiple myeloma cells. pharm res 34: 668-679. |
|
narayanan s combinatorial nanomedicine using paclitaxel and epigallocatechin gallate for breast cancer therapy. |
|
kottemann mc (2013) putting the proteasome at the end: an emerging role for the ubiquitin-â€proteasome system in dna double strand break repair. j postdoc res oct 29: 34. |
|
klemann cj, martens gj, poelmans g, visser je validity of the mptp-treated mouse as a model for parkinson’s disease. |
|